glp 1 agonist vs bariatric surgery GLP-1 Drugs vs. Bariatric Surgery Yields 5x More

It contributes to a variety of disorders, including type 2 diabetes, cardiovascular disease, hypertension, stroke, and cancer

Since being overweight or obese greatly increases the likelihood of developing colorectal cancer (CRC) [148]

Therapeutic potential of GLP-1 agonists for hidradenitis suppurativa

Actions of exendin-4 therapy on cognitive function and hippocampal synaptic plasticity in mice fed a high-fat diet

The profile of a typical heart disease patient has shifted over the past 30 years from the hypertensive, chain-smoking, type A personality to someone with overweight or obesity and concomitant diabetes

Advances in GLP-1 receptor agonists Efforts to optimize GLP-1 RAs are currently focused on enhancing efficacy, minimizing side effects, and expanding administration options